- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03086109
The Prevalence of Bone Degenerative Diseases in Beijing - a Cross-sectional Study
March 16, 2017 updated by: Wei Tian, Beijing Jishuitan Hospital
The purpose of this observational study is to investigate the prevalence and risk factors of bone degenerative diseases
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
850
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Chengai Wu, PHD
- Phone Number: +86-010-58516611
- Email: wuchengai05@163.com
Study Contact Backup
- Name: Qianqian Wang, PHD
- Phone Number: +86-15810285282
- Email: wangqianqian84@126.com
Study Locations
-
-
-
Beijing, China, 100035
- Recruiting
- Beijing Jishuitan Hospital
-
Contact:
- Chengai Wu, PHD
- Phone Number: +86-010-58516611
- Email: wuchengai05@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The residents of Beijing voluntary to participant to this study
Description
Inclusion Criteria:
- Aged 18-65 years, residents of Beijing city
- Must demonstrate willingness to participate in the study by signing the written informed consent
Exclusion Criteria:
- Subjects who had surgery on disc or knee
- Pregnent women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Ecologic or Community
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of bone degenerative diseases
Time Frame: 1 year
|
Degree of disc and knee degeneration based on imaging examination (etc.
CT OR MRI)
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Wei Tian, MD, Beijing Jishuitan Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 1, 2013
Primary Completion (Anticipated)
December 31, 2017
Study Completion (Anticipated)
December 31, 2017
Study Registration Dates
First Submitted
March 16, 2017
First Submitted That Met QC Criteria
March 16, 2017
First Posted (Actual)
March 22, 2017
Study Record Updates
Last Update Posted (Actual)
March 22, 2017
Last Update Submitted That Met QC Criteria
March 16, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012BAI10B02-Cohort
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Synergy Spine SolutionsMCRARecruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of
-
ReGelTec, Inc.Not yet recruitingDegenerative Disc Disease (DDD)
Clinical Trials on Risk factors
-
Stanford UniversityCompleted
-
Samarkand State Medical InstituteRecruiting
-
Mansoura University HospitalCompleted
-
University Children's Hospital, ZurichCompletedHypoxic Ischaemic EncephalopathySwitzerland
-
Institut National de la Santé Et de la Recherche...Completed
-
Hospital Parc Taulí, SabadellUnknownCardiovascular Disease | Osteoarthritis | Metabolic Syndrome | Cardiovascular Risk FactorsSpain
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedBreast Carcinoma | Fallopian Tube Carcinoma | Ovarian Neoplasm | Primary Peritoneal CarcinomaUnited States
-
Sheba Medical CenterMaccabi Healthcare Services, IsraelRecruitingAlzheimer DiseaseIsrael
-
Mackay Memorial HospitalRecruiting
-
Jordan Collaborating Cardiology GroupCompletedCardiovascular Diseases | Risk FactorsJordan